12 computer-aided-drug-design-phd Postdoctoral positions at Pennsylvania State University
Sort by
Refine Your Search
-
and contribute to hypothesis-driven experimental design. Prepare manuscripts and assist with grant applications. Present research findings at national and international scientific meetings. Mentor
-
holding a PhD degree in Biomedical Sciences or a related field are eligible to apply. Life sciences (Biology, Genetics, Biochemistry, etc.) PhDs with computational experience are also eligible
-
or research career. Qualifications: PhD (or MD/PhD) in cancer biology, immunology, molecular biology, genetics, or a related field. Strong background in one or more relevant research areas (Pharmacology, Drug
-
of head and neck squamous cell carcinoma (HNSCC). The overarching goal of the research program is to identify biologic determinants of tumor control and normal tissue injury following radiation therapy, and
-
quantum information science. Specific topics of interest include dynamics in closed and open quantum systems, digital and analog quantum simulation with quantum computers or atomic-physics platforms, and
-
PhD degree in Computer Science, Math, Statistics (in hand at time of hire) or a related field are eligible to apply. Life sciences (Biology, Genetics, Biochemistry, etc.) PhDs with computational
-
plant pathogens in organic production systems through a multi-institutional USDA/OREI funded project. The Postdoctoral Scholar will conduct or coordinate research computational analysis and pattern
-
Experience A PhD in Physics, Astronomy, Computer Science, or a closely related field is required. Experience with HPC systems, jax, python, or similar programming languages, machine learning, and transient/AGN
-
Telescope and WIYN telescope. Computing access is supplied by the Penn State Institute for Computational and Data Sciences . Education and Experience A PhD in Physics, Astronomy, or a closely related field is
-
. We have multiple NIH-funded projects to study the influence of FDA-approved GLP-1R agonists on drug seeking and reinstatement in rodents. A newly funded NIH R01 has the goal to determine who may be